SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 328 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,000 | -87.5% | 11 | -88.9% | 0.00% | – |
| Q1 2022 | $8,000 | -11.1% | 99 | 0.0% | 0.00% | – |
| Q4 2021 | $9,000 | 0.0% | 99 | 0.0% | 0.00% | – |
| Q3 2021 | $9,000 | +12.5% | 99 | -4.8% | 0.00% | – |
| Q2 2021 | $8,000 | 0.0% | 104 | 0.0% | 0.00% | – |
| Q1 2021 | $8,000 | +300.0% | 104 | +1385.7% | 0.00% | – |
| Q4 2020 | $2,000 | -66.7% | 7 | -82.9% | 0.00% | – |
| Q3 2020 | $6,000 | -100.0% | 41 | -100.0% | 0.00% | -100.0% |
| Q2 2020 | $38,658,000 | +63.9% | 241,103 | +0.0% | 0.12% | +28.4% |
| Q1 2020 | $23,584,000 | -24.2% | 241,096 | 0.0% | 0.10% | -5.9% |
| Q4 2019 | $31,111,000 | -6.4% | 241,096 | +10.3% | 0.10% | -9.8% |
| Q2 2019 | $33,223,000 | +474514.3% | 218,644 | +383486.0% | 0.11% | – |
| Q1 2019 | $7,000 | -96.2% | 57 | -96.6% | 0.00% | -100.0% |
| Q4 2018 | $183,000 | +4475.0% | 1,666 | +7143.5% | 0.00% | – |
| Q3 2018 | $4,000 | -92.9% | 23 | -97.7% | 0.00% | – |
| Q4 2017 | $56,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 1,195,000 | $142,432,000 | 6.16% |
| Casdin Capital, LLC | 305,000 | $36,353,000 | 3.99% |
| Eventide Asset Management | 845,168 | $100,736,000 | 3.47% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 436,000 | $51,967,000 | 3.26% |
| NEXTHERA CAPITAL LP | 21,270 | $2,535,000 | 3.08% |
| Camber Capital Management LP | 500,000 | $59,595,000 | 2.97% |
| Eversept Partners, LP | 83,574 | $9,961,185 | 2.91% |
| CADIAN CAPITAL MANAGEMENT, LP | 610,546 | $72,771,000 | 2.84% |
| RTW INVESTMENTS, LP | 338,199 | $40,310,000 | 2.75% |
| Cormorant Asset Management, LP | 300,000 | $35,757,000 | 2.42% |